Denbaars Steven 4
4 · Palomino Laboratories Inc. · Filed Oct 9, 2025
Insider Transaction Report
Form 4
Denbaars Steven
Director
Transactions
- Sale
Warrants
2025-09-29$1.20/sh+125,000$150,000→ 125,000 totalExercise: $1.50From: 2025-09-29→ Common Stock (125,000 underlying) - Other
Common Stock
2025-09-29+1,625,000→ 1,750,000 total
Footnotes (1)
- [F1]Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. DenBaars, as a shareholder of Pre-Merger Palomino, received 1,500,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, during which, Mr. DenBaars converted his SAFEs into 125,000 Units at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in warrant agreement).